Breast health

Progesterone and breast cancer — References & further reading

References

¹ Campagnoli, C., et al. 2005. Progestins and progesterone in hormone replacement therapy and the risk of breast cancer. J. Steroid Biochem. Mol. Biol., 96 (2), 95–108.

² Wood, C., et al. 2007. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys. Breast Cancer Res. Treat., 101 (2), 125–134.

Campagnoli, C., et al. 2005. Pregnancy, progesterone and progestins in relation to breast cancer risk. J. Steroid Biochem. Mol. Biol., 97 (5), 441–450.

³ Women’s Health Initiative Participant Website. June 2003. Estrogen plus progestin effects on breast cancer and mammograms. URL: http://www.whi.org/findings/ht/eplusp_bc.php (accessed 02.20.2007).

Kolata, G. 12/26/2006. Hormones and cancer: Assessing the risks. NYT. URL: http://query.nytimes.com/gst/fullpage.html
?sec=health&res=9B02E7DC1E31F935A15751C1A9609C8B63

⁴ Wikipedia. 02/11/2007. Progestin. URL: http://en.wikipedia.org/wiki/Progestin (accessed 02.21.2007).

⁵ Hrushesky, W. 1996. Breast cancer, timing of surgery, and the menstrual cycle: Call for prospective trial. J. Women's Health, 5 (6), 555–566.

Sainsbury, R. 1993. Timing of surgery for breast cancer in relation to the menstrual cycle and survival of premenopausal women. Br. J. Surg., 80 (5), 670.

Nathan, B., et al. 1993. Timing of surgery for breast cancer in relation to the menstrual cycle and survival of premenopausal women. Br. J. Surg., 80 (1), 43.

Badwe, R., et al. 1991. Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer. Lancet, 337 (8752), 1261–1264.

⁶ Chang, K., et al. 1995. Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo. Fert. Steril., 63 (4), 785–791.

Foidart, J., et al. 1998. Estradiol and progesterone regulate the proliferation of human breast epithelial cells. Fertil. Steril., 69 (5), 963–969.

⁷ Campagnoli, C., et al. 2005. Pregnancy, progesterone and progestins in relation to breast cancer risk. J. Steroid Biochem. Mol. Biol., 97 (5), 441-450.

⁸ Fabre, A., et al. 2007. Oral progestagens before menopause and breast cancer risk. Br. J. Cancer, 96, 841–844.

Fournier, et al. 2004. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N–EPIC cohort. Int. J. Cancer, 114 (3), 448–454. URL: http://www3.interscience.wiley.com/
cgi-bin/abstract/109795649/ABSTRACT (abstract only; accessed 02.21.2007).

De Lignieres, B., et al. 2002. Combined hormone replacement therapy and risk of breast cancer in a French cohort study of 3175 women. Climacteric, 5 (4), 332–340.

⁹ Parker–Pope, T. 02.20.2007. Hormone patch shows benefit over pill. Wall Street Journal. URL: http://online.wsj.com/article_email/SB117193377486713149
-lMyQjAxMDE3NzIxMDkyMzAzWj.html (accessed 02.20.2007; subscription may be required for full access).

¹⁰ Lord, S., et al. 2005. Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: Results from a pilot study. Breast Cancer Res., 7 (3), R336–344.